Estimo, Marvin .

HRN: 24-04-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
CEFUROXIME 1.5GM (VIAL)
07/04/2024
07/11/2024
IVT
1.5 Grams
1 HR PTOR
HEMORRHOIDS
Waiting Final Action 
07/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2024
07/11/2024
IVT
500 MG
Q8H
HEMORRHOIDS
Waiting Final Action 
07/05/2024
CEFUROXIME 500MG (TAB)
07/06/2024
07/12/2024
ORAL
500mg
Q8
Post Op Wound
Waiting Final Action 
07/05/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/05/2024
07/06/2024
IV
500mg
Q8 X 3 Doses Only
Post-op Prophylaxis
Waiting Final Action 
07/05/2024
METRONIDAZOLE 500MG (TAB)
07/06/2024
07/12/2024
PO
500mg
Q8
Post-op Prophylaxis
Waiting Final Action 
07/05/2024
CEFUROXIME 1.5GM (VIAL)
07/05/2024
07/06/2024
IVTT
1.5g
Q8 X 3 Doses
Post-op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: